Childhood, adolescent and young adult non‐Hodgkin lymphoma: current perspectives
MS Cairo, A Beishuizen - British journal of haematology, 2019 - Wiley Online Library
Summary The 6th International Symposium on Childhood, Adolescent and Young Adult
(CAYA) Non‐Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26–29 …
(CAYA) Non‐Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26–29 …
Burkitt's lymphoma
M Roschewski, LM Staudt… - New England Journal of …, 2022 - Mass Medical Soc
Burkitt’s Lymphoma | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical …
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical …
Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma
Y Liu, B Deng, B Hu, W Zhang, Q Zhu, Y Liu… - Blood …, 2022 - ashpublications.org
Single antigen–targeted chimeric antigen receptor (CAR) T-cell therapy may be insufficient
to induce a durable response in pediatric aggressive B-cell lymphomas. This clinical trial …
to induce a durable response in pediatric aggressive B-cell lymphomas. This clinical trial …
Лимфома Беркитта у детей: 30 лет терапии
ТТ Валиев - Педиатрия. Журнал им. ГН Сперанского, 2020 - elibrary.ru
ЛимфомаБеркитта (ЛБ) у детей-это пример того, как потенциально фатальное
заболевание благодаря современным достижениям химиотерапии стало излечимым у …
заболевание благодаря современным достижениям химиотерапии стало излечимым у …
Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents
A Attarbaschi, O Abla, L Ronceray, S Bansil… - Blood …, 2019 - ashpublications.org
Key Points Children with PCNSL and no immunodeficiency have a good outcome when
treated by a histological subtype–driven and radiation-free protocol. New treatment …
treated by a histological subtype–driven and radiation-free protocol. New treatment …
[HTML][HTML] Targeting MYC-driven lymphoma: lessons learned and future directions
S Martínez-Martín, ME Beaulieu… - Cancer Drug …, 2023 - ncbi.nlm.nih.gov
MYC plays a central role in tumorigenesis by orchestrating cell proliferation, growth and
survival, among other transformation mechanisms. In particular, MYC has often been …
survival, among other transformation mechanisms. In particular, MYC has often been …
Novel therapies potentially available for pediatric B-cell non-Hodgkin lymphoma
PD Harker-Murray, L Pommert, MJ Barth - Journal of the National …, 2020 - jnccn.org
Burkitt lymphoma, diffuse large B-cell lymphoma (DLBCL), and primary mediastinal B-cell
lymphoma are the most common aggressive pediatric mature B-cell non-Hodgkin …
lymphoma are the most common aggressive pediatric mature B-cell non-Hodgkin …
Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second …
A Maschan, N Myakova, O Aleinikova… - British Journal of …, 2019 - Wiley Online Library
The value of adding rituximab to chemotherapy in children with aggressive B‐cell non‐
Hodgkin lymphoma (B‐NHL) is still insufficiently studied. We enrolled 231 patients [mean …
Hodgkin lymphoma (B‐NHL) is still insufficiently studied. We enrolled 231 patients [mean …
Co-occurrence of Pallister-Killian syndrome and Burkitt lymphoma in a patient with near-normal neurocognitive development
K Izumi, RD Ganetzky, GBW Wertheim… - Molecular …, 2023 - karger.com
Abstract Background: Pallister-Killian syndrome (PKS) is typically recognized by its features
that include developmental delay, seizures, sparse temporal hair, and facial dysmorphisms …
that include developmental delay, seizures, sparse temporal hair, and facial dysmorphisms …
Management of aggressive non-Hodgkin lymphomas in the pediatric, adolescent, and young adult population: An adult vs. pediatric perspective
IN Sheikh, A Elgehiny, D Ragoonanan, KM Mahadeo… - Cancers, 2022 - mdpi.com
Simple Summary This review details the diagnosis and treatment of primary non-Hodgkin
lymphoma (NHL) in the pediatric and adolescent population. We also describe treatment …
lymphoma (NHL) in the pediatric and adolescent population. We also describe treatment …